Maqola

CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS

Faizullaeva N. Ya.Institute of Human Immunology and Genomics of theMukhtorov Sh. M.Raufov A. A.Institute of Human Immunology and Genomics of the Academy of Sciences of the Republic of Uzbekistan

2025en

Ochiq kirishOlmos

Litsenziya: cc-by

Manbada oʻqishusajournals.org(yangi oynada ochiladi)
PDFusajournals.org(yangi oynada ochiladi)

ABI

Annotatsiya

The relevance of the study is due to the high frequency of bronchial asthma (BA) and type 2 diabetes mellitus (T2DM), which mutually aggravate each other. The aim of the study was to investigate clinical and immunobiochemical markers to optimize the diagnosis and assess the severity of BA combined with T2DM.

Hali tarjima qilinmagan

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba